Nafithromycin

那非霉素

Report date: 2026/01/30 17:56:53
NMEQIDP

Base Information

Drug NameNafithromycin
Drug Alias Namenafithromycinum纳非霉素nafitromicinanafithromycineMiqnaf +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionProtein synthesis inhibitors50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsCommunity-acquired bacterial pneumoniaPneumonia, Bacterial
Global Approved IndicationsCommunity-acquired bacterial pneumonia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2025/01/02
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWockhardt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Ltd
Inactive CompaniesN/A
Active IndicationsCommunity-acquired bacterial pneumonia
Inactive IndicationsPneumonia, Bacterial

Other Information

ATC CodeN/A
Related LinksWikipedia